Reporting of myelotoxicity associated wtih emerging regimems for the treatment of selected solid tumors
| dc.contributor.author | Chan, Arlene | |
| dc.contributor.author | Verma, S. | |
| dc.contributor.author | Loibl, S. | |
| dc.contributor.author | Crawford, J. | |
| dc.contributor.author | Choi, M.R. | |
| dc.contributor.author | Dreiling, L. | |
| dc.contributor.author | Vandenberg, T. | |
| dc.date.accessioned | 2017-01-30T12:04:09Z | |
| dc.date.available | 2017-01-30T12:04:09Z | |
| dc.date.created | 2014-11-19T01:13:19Z | |
| dc.date.issued | 2012 | |
| dc.identifier.citation | Chan, A. and Verma, S. and Loibl, S. and Crawford, J. and Choi, M.R. and Dreiling, L. and Vandenberg, T. 2012. Reporting of myelotoxicity associated wtih emerging regimems for the treatment of selected solid tumors. Critical Reviews in Oncology/Hematology. 81: pp. 136-150. | |
| dc.identifier.uri | http://hdl.handle.net/20.500.11937/17811 | |
| dc.publisher | Elsevier | |
| dc.title | Reporting of myelotoxicity associated wtih emerging regimems for the treatment of selected solid tumors | |
| dc.type | Journal Article | |
| dcterms.source.volume | 81 | |
| dcterms.source.startPage | 136 | |
| dcterms.source.endPage | 150 | |
| dcterms.source.issn | 10408428 | |
| dcterms.source.title | Critical Reviews in Oncology/Hematology | |
| curtin.accessStatus | Fulltext not available |